TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully Than That to Infliximab/Adalimumab in Spondyloarthritis
Scientific Reports - United Kingdom
doi 10.1038/srep32202
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 31, 2016
Authors
Publisher
Springer Science and Business Media LLC